help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laporte, S. A.
Right arrow Articles by Escher, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laporte, S. A.
Right arrow Articles by Escher, E.
Molecular Endocrinology 13 (4): 578-586
Copyright © 1999 by The Endocrine Society

Determination of Peptide Contact Points in the Human Angiotensin II Type I Receptor (AT1) with Photosensitive Analogs of Angiotensin II

Stéphane A. Laporte, Antony A. Boucard, Guy Servant, Gaétan Guillemette, Richard Leduc and Emanuel Escher

Department of Pharmacology Medical School Université de Sherbrooke Sherbrooke, Québec J1H 5N4 Canada

To identify ligand-binding domains of Angiotensin II (AngII) type 1 receptor (AT1), two different radiolabeled photoreactive AngII analogs were prepared by replacing either the first or the last amino acid of the octapeptide by p-benzoyl-L-phenylalanine (Bpa). High yield, specific labeling of the AT1 receptor was obtained with the 125I-[Sar1,Bpa8]AngII analog. Digestion of the covalent 125I-[Sar1,Bpa8]AngII-AT1 complex with V8 protease generated two major fragments of 15.8 kDa and 17.8 kDa, as determined by SDS-PAGE. Treatment of the [Sar1,Bpa8]AngII-AT1 complex with cyanogen bromide produced a major fragment of 7.5 kDa which, upon further digestion with endoproteinase Lys-C, generated a fragment of 3.6 kDa. Since the 7.5-kDa fragment was sensitive to hydrolysis by 2-nitro-5-thiocyanobenzoic acid, we circumscribed the labeling site of 125I-[Sar1,Bpa8]AngII within amino acids 285 and 295 of the AT1 receptor. When the AT1 receptor was photolabeled with 125I-[Bpa1]AngII, a poor incorporation yield was obtained. Cleavage of the labeled receptor with endoproteinase Lys-C produced a glycopeptide of 31 kDa, which upon deglycosylation showed an apparent molecular mass of 7.5 kDa, delimiting the labeling site of 125I-[Bpa1]AngII within amino acids 147 and 199 of the AT1 receptor. CNBr digestion of the hAT1 I165M mutant receptor narrowed down the labeling site to the fragment 166–199. Taken together, these results indicate that the seventh transmembrane domain of the AT1 receptor interacts strongly with the C-terminal amino acid of [Sar1, Bpa8]AngII, whereas the N-terminal amino acid of [Bpa1]AngII interacts with the second extracellular loop of the AT1 receptor.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Domazet, S. S. Martin, B. J. Holleran, M.-E. Morin, P. Lacasse, P. Lavigne, E. Escher, R. Leduc, and G. Guillemette
The Fifth Transmembrane Domain of Angiotensin II Type 1 Receptor Participates in the Formation of the Ligand-binding Pocket and Undergoes a Counterclockwise Rotation upon Receptor Activation
J. Biol. Chem., November 13, 2009; 284(46): 31953 - 31961.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Clement, J. Cabana, B. J. Holleran, R. Leduc, G. Guillemette, P. Lavigne, and E. Escher
Activation Induces Structural Changes in the Liganded Angiotensin II Type 1 Receptor
J. Biol. Chem., September 25, 2009; 284(39): 26603 - 26612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Domazet, B. J. Holleran, S. S. Martin, P. Lavigne, R. Leduc, E. Escher, and G. Guillemette
The Second Transmembrane Domain of the Human Type 1 Angiotensin II Receptor Participates in the Formation of the Ligand Binding Pocket and Undergoes Integral Pivoting Movement during the Process of Receptor Activation
J. Biol. Chem., May 1, 2009; 284(18): 11922 - 11929.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Clement, S. S. Martin, M.-E. Beaulieu, C. Chamberland, P. Lavigne, R. Leduc, G. Guillemette, and E. Escher
Determining the Environment of the Ligand Binding Pocket of the Human Angiotensin II Type I (hAT1) Receptor Using the Methionine Proximity Assay
J. Biol. Chem., July 22, 2005; 280(29): 27121 - 27129.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Martin, A. A. Boucard, M. Clement, E. Escher, R. Leduc, and G. Guillemette
Analysis of the Third Transmembrane Domain of the Human Type 1 Angiotensin II Receptor by Cysteine Scanning Mutagenesis
J. Biol. Chem., December 3, 2004; 279(49): 51415 - 51423.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Auger-Messier, M. Clement, P. M. Lanctot, P. C. Leclerc, R. Leduc, E. Escher, and G. Guillemette
The Constitutively Active N111G-AT1 Receptor for Angiotensin II Maintains a High Affinity Conformation Despite Being Uncoupled from Its Cognate G Protein Gq/11{alpha}
Endocrinology, December 1, 2003; 144(12): 5277 - 5284.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Sachon, G. Bolbach, G. Chassaing, S. Lavielle, and S. Sagan
Cgamma H2 of Met174 Side Chain Is the Site of Covalent Attachment of a Substance P Analog Photoactivable in Position 5
J. Biol. Chem., December 20, 2002; 277(52): 50409 - 50414.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. C. Leclerc, M. Auger-Messier, P. M. Lanctot, E. Escher, R. Leduc, and G. Guillemette
A Polyaromatic Caveolin-Binding-Like Motif in the Cytoplasmic Tail of the Type 1 Receptor for Angiotensin II Plays an Important Role in Receptor Trafficking and Signaling
Endocrinology, December 1, 2002; 143(12): 4702 - 4710.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-i. Miura and S. S. Karnik
Constitutive Activation of Angiotensin II Type 1 Receptor Alters the Orientation of Transmembrane Helix-2
J. Biol. Chem., June 28, 2002; 277(27): 24299 - 24305.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. M. Martin, B. M. Willardson, G. F. Burton, C. R. White, J. N. McLaughlin, S. M. Bray, J. W. Ogilvie Jr., and T. S. Elton
Human Angiotensin II Type 1 Receptor Isoforms Encoded by Messenger RNA Splice Variants Are Functionally Distinct
Mol. Endocrinol., February 1, 2001; 15(2): 281 - 293.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society